Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
BACKGROUND: Osteoprotegerin (OPG) is a tumour and/or bone derived factor that may protect tumour cells from apoptosis. In this study, we have measured serum OPG levels in untreated prostate cancer patients with advanced prostate cancer compared to patients with organ confined disease and in treated...
Үндсэн зохиолчид: | Eaton, C, Wells, J, Holen, I, Croucher, P, Hamdy, F |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2004
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
-н: Eaton, C, зэрэг
Хэвлэсэн: (2004) -
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
-н: Holen, I, зэрэг
Хэвлэсэн: (2002) -
Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
-н: Holen, I, зэрэг
Хэвлэсэн: (2002) -
Role of osteoprotegerin (OPG) in cancer.
-н: Holen, I, зэрэг
Хэвлэсэн: (2006) -
The role of osteoprotegerin in breast and prostate cancer
-н: Holen, I, зэрэг
Хэвлэсэн: (2002)